| mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.004 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.004 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.005 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.006 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.007 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |